We tested the association of IR and diabetic status to aggregated tau, using MK-6240 PET, in a sample enriched for AD risk due to an increased proportion of APOE ε4 allele carriers and comprised largely of middle-aged and older adults who were cognitively unimpaired. This evidence concerns the gene MAPT and Alzheimer disease.